Pseudomonas aeruginosa recombinant L-asparaginase: Large scale production, purification, and cytotoxicity on THP-1, MDA-MB-231, A549, Caco2 and HCT-116 cell lines.


Journal

Protein expression and purification
ISSN: 1096-0279
Titre abrégé: Protein Expr Purif
Pays: United States
ID NLM: 9101496

Informations de publication

Date de publication:
05 2021
Historique:
received: 07 09 2020
revised: 02 12 2020
accepted: 03 01 2021
pubmed: 14 1 2021
medline: 25 12 2021
entrez: 13 1 2021
Statut: ppublish

Résumé

In previous studies Pseudomonas aeruginosal-ASNase complete coding sequence gene, 984 bp (GenBank accession number KU161101.2) was isolated by PCR, cloned into pET28a(+) vector, expressed in E. coli DE3(BL21) pLysS, purified to apparent homogeneity and biochemically characterized. In the present work we highlight large scale production, affinity purification of the recombinant enzyme, effect of osmolytes on the stability of the l-ASNase and cytotoxicity on different cancer cell lines. Successful overexpression was achieved in E. coli as a 6-His-Tag fusion protein after 18 h of induction with lactose at a concentration of 2 g/L in fermentation medium and at 37 °C. The recombinant enzyme was purified to homogeneity using Ni

Identifiants

pubmed: 33440252
pii: S1046-5928(21)00003-6
doi: 10.1016/j.pep.2021.105820
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Bacterial Proteins 0
Recombinant Proteins 0
Asparaginase EC 3.5.1.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105820

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Hesham Saeed (H)

Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt. Electronic address: hsaeed1@ksu.edu.sa.

Asmaa Hemida (A)

Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt.

Manal Abdel-Fattah (M)

Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt.

Ahmad Eldoksh (A)

Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt.

Manal Shalaby (M)

Department of Medical Biotechnology, Genetic Engineering and Biotechnology Research Institute (GEBRI), City for Scientific Research and Technology Applications, New Borg Al-Arab City, Alexandria, Egypt.

Hisham Nematalla (H)

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Damanhur University, Damnhour, Egypt.

Nefertiti El-Nikhely (N)

Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt.

Mohamed Elkewedi (M)

Department of Medical Laboratory Technology, Faculty of Applied Health Sciences Technology, Pharos University in Alexandria, Alexandria, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH